Inside the Global Proteomics Market, A Deep-diving study Report by MRFR for 2018-2023


Market Overview:
The Global Proteomics Market is rising pervasively mainly due to the proliferating trend of personalized medicines. Proteomics is used in drug discovery and clinical diagnosis for a number of applications such as the investigation of protein expression, metabolic pathways, transcriptional & post-transcriptional studies, protein interaction in diseases, etc. Moreover, the burgeoning sectors such as healthcare and pharmaceutical escalate the market on the global platform.
Analyzing the ascending graph of the growth, the market is climbing steadily, Market Research Future (MRFR), in its recently published study report confirms that the global Proteomics Market will quadruple by 2023, registering a staggering double-digit CAGR over 14.1 % throughout the forecast period (2018 to 2023). In 2017, the market had accounted for a valuation of USD 23.2 BN.
Additional factors that are boosting the growth of the market include the increasing research & development activities predominantly led by the government support, rising demand for personalized medicines, and the rising number of approvals of personalized medicines. Furthermore, increasing activities of drug discovery in the rapidly proliferating pharmaceutical industry foster the growth of the market to an extent.
Global Proteomics Market – Competitive Analysis
The widely expanded Proteomics market appears to be highly competitive with the presence of numerous large and small-scale players. These players compete against each other based on an array of services and pricing. Naturally, the competitive strength of these players is reliant on service pricing, service precision, versatility, and reliability of services. The market is forecasted to witness fierce competition with the potential extensions in innovations. Players operating in the Proteomics market strive to offer unique services with advanced features.
Focusing on rapid expansion and integration set for 2019-2019, these service providers build a company that can offer complementary services in key regions, in the emerging market.
While acquiring a company, they ensure to acquire a company with significant professional experience, state-of-the-art capabilities, and a long history of delivering high-quality pharmaceuticals that can meet or exceed customer expectations and regulatory requirements.
Major Players:
·         Bio-Rad Laboratories
·         General Electric Company
·         Danaher
·         Siemens Ltd
·         Agilent Technologies
·         Thermo Fisher Scientific Inc
·         Genzyme Corporation
·         Bruker
·         Biognosys AG
·         Luminex Corporation
·         PerkinElmer Inc
Global
Proteomics Market – Segments
For ease of understanding, the report is segmented into four key dynamics: -

By Equipment           : Chromatography, X-ray Crystallography, Protein Fractionation, Mass Spectroscopy, and Protein Microarray among others.

By Services               : Laboratory Services, and Data Analysis & Services among others.

By Application          : Drug Discovery and Clinical Diagnosis among others.

By Regions                : North America, Asia Pacific, Europe, and the Rest-of-the-World.
Global Proteomics Market – Geographical Analysis
The North American region, heading with the rising funding from government dominates the global Proteomics market. Moreover, factor such as the spreading awareness towards cost-effective applications of proteomics and increasing demand for personalized medicines drive the growth of the regional market. The increasing consumption of medicines led by the prevalence of chronic diseases, well-established healthcare sector, and the growing trend of personalized medicines are some of the other key driving forces behind the market growth in the region.
Also, factors such as the high healthcare expenditures, and augmenting demand for the novel drug discoveries substantiate the growth of the Proteomics market in the North American region.  The North America Proteomics market is projected to grow at a substantial CAGR, creating a larger revenue pocket by 2023.
The Proteomics market in the European region accounts for the second-largest market, globally. Factors such as financial support by the government for cancer research activities and the patent expiration of numerous blockbuster drugs are estimated to drive the regional Proteomics market. Furthermore, the burgeoning pharmaceutical industry is a key driving force fostering the growth of the regional market and allowing it to grow at a considerable CAGR.
The Asia Pacific Proteomics market is rapidly emerging as a promising market, globally. The availability of cost-competitive skilled labor force and raw materials are the key driving forces behind the growth of the regional market, encouraging foreign investors to shift their production bases in this rapidly growing market.
Additionally, factors such as the huge developments in the pharmaceutical sector, demand for breakthrough drug discoveries, and huge patient pool propels the growth in the regional market. The increasing demand for personalized medicine that is led by the rising prevalence of cancer and other such diseases and presence of a large number of manufacturers of personalized drugs will support the regional market to register a phenomenal CAGR throughout the forecast period.


Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more